SPINK1 protein binds to EGFR and activates its downstream signals, leading to the progression of pancreatic cancer, prostate cancer, bladder cancer (BCa), pancreatic ductal adenocarcinoma and breast cancer cells (Figure 1) (79–83). Here, SPINK1 is linked to prostate carcinoma.